Header Logo

Connection

Prabhakara Nagareddy to Liver

This is a "connection" page, showing publications Prabhakara Nagareddy has written about Liver.
Connection Strength

0.944
  1. It's reticulated: the liver at the heart of atherosclerosis. J Endocrinol. 2018 07; 238(1):R1-R11.
    View in: PubMed
    Score: 0.499
  2. Genetic Deletion of Syndecan-4 Alters Body Composition, Metabolic Phenotypes, and the Function of Metabolic Tissues in Female Mice Fed A High-Fat Diet. Nutrients. 2019 Nov 18; 11(11).
    View in: PubMed
    Score: 0.139
  3. SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice. Atherosclerosis. 2018 04; 271:166-176.
    View in: PubMed
    Score: 0.123
  4. Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice. Arterioscler Thromb Vasc Biol. 2015 Jan; 35(1):102-10.
    View in: PubMed
    Score: 0.098
  5. Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway. Endocrinology. 2012 Nov; 153(11):5143-9.
    View in: PubMed
    Score: 0.084
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.